What does 2022 hold for the biopharma industry? Which companies can play at the forefront in terms of products as well as business? Covid-19 will continue to be a...
Swiss drugmaker Roche has launched a genomic profiling kit that it has developed in conjunction with Foundation Medicine. The Basel-based company is supplying the kit...
Swiss drugmaker Roche has acquired Irish biotech Inflazome for €380 million, said to be one of the largest deals in Irish biotech history. Headquartered in Dublin...
UK biopharma Celleron Therapeutics has signed a licensing deal with Roche, gaining exclusive worldwide rights to the Swiss pharma’s monoclonal antibody emactuzumab, which...
Roche has announced two separate collaborations, one for an investigational cancer treatment and the other for the discovery of small molecule drugs for treating immune...
09.06.2020
- Pierre-Alain Ruffieux has been appointed CEO of Swiss CDMO Lonza, with effect from 1 November 2020. The new chief executive will succeed Marc Funk, who led the company from March...
22.05.2020
- Roche has signed a worldwide option and license agreement with Vividion Therapeutics, gaining access to the latter’s proteomics screening platform and proprietary small molecule...
15.04.2020
- Swiss drugmaker Roche has entered into a strategic collaboration and license agreement with US biopharma Arrakis Therapeutics for the discovery of RNA-targeted small molecule (rSM)...
